151 results on '"Richaud-Patin, Yvonne"'
Search Results
2. Reprogramming Captures the Genetic and Tumorigenic Properties of Neurofibromatosis Type 1 Plexiform Neurofibromas
3. Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease
4. Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A
5. iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology
6. iPSC-Based Modeling of Variable Clinical Presentation in Hypertrophic Cardiomyopathy
7. Activity and High-Order Effective Connectivity Alterations in Sanfilippo C Patient-Specific Neuronal Networks
8. P-glycoprotein activity in renal clear cell carcinoma
9. Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency
10. Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease
11. Patient-Specific iPSC-Derived Cellular Models of LGMDR1
12. Inflammatory profile in the cerebrospinal fluid of patients with central neuropsychiatric lupus, with and without associated factors
13. An Unusual Multiplex Systemic Lupus Erythematosus Family With High Prevalence of Nephropathy, Late-Onset Disease, and One Member With Disease-Onset Post-HIV Therapy
14. Macrofollicular variant of papillary thyroid carcinoma: A case and control analysis
15. P-glycoprotein in autoimmune diseases
16. Multidrug resistance-1 (MDR-1) in autoimmune disorders IV. P-glycoprotein overfunction in lymphocytes from myasthenia gravis patients
17. Class I and class II MHC polymorphisms in Mexican patients with Behçet’s disease
18. Lupus Nephritis Outcome With and Without Renal Biopsy: A 5-Year Comparative Study
19. In vivo IL-10 and TGF-β production by PBMC from long-term kidney transplant recipients with excellent graft function: a possible feedback mechanism participating in immunological stability
20. Weekly leflunomide as monotherapy for recent-onset rheumatoid arthritis
21. Multidrug resistance-1 (MDR-1) in autoimmune disorders III: Increased P-glycoprotein activity inlymphocytes from immune thrombocytopenic purpura patients
22. CLINICAL AND BIOLOGIC EFFECTS OF ANTI–INTERLEUKIN-10 MONOCLONAL ANTIBODY ADMINISTRATION IN SYSTEMIC LUPUS ERYTHEMATOSUS
23. Weekly dose of leflunomide for the treatment of refractory rheumatoid arthritis: an open pilot comparative study
24. Traitement de la polyarthrite rhumatoïde par une dose hebdomadaire de leflunomide. Étude ouverte comparative
25. DYSREGULATION OF INTERLEUKIN-10 PRODUCTION IN RELATIVES OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
26. Cytokine gene expression in cirrhotic and non-cirrhotic human liver
27. Innate immune mechanisms in the pathogenesis of systemic lupus erythematosus (SLE)
28. Human leukocyte antigen class I, class II, and tumor necrosis factor-alpha polymorphisms in a healthy elder Mexican Mestizo population
29. Phénotype MDR-I de multirésistance aux traitements de fond dans les maladies rhumatismales auto-immunes: Première partie : une activité accrue de la P-glycoprotéine lymphocytaire pourrait influencer l'évolution de la polyarthrite rhumatdïde
30. iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology
31. iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the Y218N PRNP Mutation Recapitulate tau Pathology
32. iPS Cell Cultures from a Gerstmann-Sträussler-Scheinker Patient with the <italic>Y218N PRNP</italic> Mutation Recapitulate tau Pathology.
33. A protocol describing the genetic correction of somatic human cells and subsequent generation of iPS cells
34. Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells under Xeno-free Conditions
35. Human leukocyte antigen class I, class II, and tumor necrosis factor-alpha polymorphisms in a healthy elder Mexican Mestizo population
36. Weekly leflunomide as monotherapy for recent‐onset rheumatoid arthritis
37. The role of interleukin-10 in systemic lupus erythematosus
38. Innate immune response mechanisms in non-insulin dependent diabetes mellitus patients assessed by flow cytoenzymology
39. High Prevalence of Protein-Dependent and Protein-Independent Antiphospholipid and Other Autoantibodies in Healthy Elders
40. Role of IL-10 in the Abnormalities of Early Cell Activation Events of Lymphocytes from Patients with Systemic Lupus Erythematosus
41. Clinical Behavior and Prognostic Factors of Periampullary Adenocarcinoma
42. In vivo production of interleukin-10 by non–t cells in rheumatoid arthritis, sjöugren's syndrome, and systemic lupus erythematosus.
43. Clinical Behavior and Prognostic Factors of Periampullary Adenocarcinoma
44. Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells under Xeno-free Conditions.
45. Deficiency of red cell bound CD55 and CD59 in patients with systemic lupus erythematosus
46. Cuatro casos de cáncer de paratiroides.
47. Spontaneous cytokine gene expression by cultured skin fibroblasts of systemic sclerosis. Correlation with collagen synthesis.
48. Clinical and biologic effects of antiinterleukin-10 monoclonal antibody administration in systemic lupus erythematosus
49. Lupus nephritis remission, albeit with positive anti-doping test
50. Rémission d'une néphrite lupique, malgré un test antidopage positif
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.